Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Elections Post Observer.
Press releases published on January 23, 2026
January 23, 2026
KTS Global CEO Tim Jacobs appointed to The Hanwell Group Advisory Council
Indeterminate
EIN Presswire
January 23, 2026
Good Dad Act Committee Celebrates Historic Achievements and Champions Nationwide Family Law Reform
Indeterminate
EIN Presswire
January 23, 2026
Larry Rubin Campaign Files First FEC Report, Becomes Fastest-Growing Campaign in TX-38
Indeterminate
EIN Presswire
January 23, 2026
Cheap Lands for Sale in Abuja: Genuine Listings Backed by Verification
Indeterminate
EIN Presswire
January 23, 2026
LEADING EDGE MATERIALS REPORTS FISCAL 2025 RESULTS
Indeterminate
GlobeNewswire
January 23, 2026
FRO – Time Charter-Out Contracts for Seven VLCCs
Indeterminate
GlobeNewswire
January 23, 2026
VeritasChain Holds Chair-Level Dialogue with UN ITU-T SG17 and Meets SECP on Verifiable AI Audit Trails
Indeterminate
EIN Presswire
January 23, 2026
Transaction in Own Shares
Indeterminate
GlobeNewswire
January 23, 2026
Wyman & Williamson Study Reveals the Percentage of Criminal Charges in Calgary That End in Conviction
Indeterminate
GlobeNewswire
January 23, 2026
Virtune meddelar kommande ETP split 10:1 för Virtune Bitcoin Prime ETP (VIRBTCP)
Indeterminate
GlobeNewswire
January 23, 2026
Virtune Announces Upcoming 10:1 Share Split for the Virtune Bitcoin Prime ETP (VIRBTCP)
Indeterminate
GlobeNewswire
January 23, 2026
대한민국 국가 위기 타개 위한 무결점‘다면적 전방위 개입 전략’정부 제출
Indeterminate
EIN Presswire
January 23, 2026
VALLOUREC TO SHOWCASE DELPHY, ITS INNOVATIVE HYDROGEN STORAGE SOLUTION, AT HYVOLUTION 2026
Indeterminate
GlobeNewswire
January 23, 2026
VALLOUREC PRÉSENTERA DELPHY, SA SOLUTION INNOVANTE DE STOCKAGE D’HYDROGÈNE, À HYVOLUTION 2026
Indeterminate
GlobeNewswire
January 23, 2026
Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
Indeterminate
GlobeNewswire
January 23, 2026
Communiqué de presse : L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique
Indeterminate
GlobeNewswire